World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
45
Citations
14214
World Ranking
4665
National Ranking
2101

Tanya M. Laidlaw publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Tanya M. Laidlaw sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 221 publications — 42nd percentile

42% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Tanya M. Laidlaw D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Tanya M. Laidlaw sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 45 D-Index — 6th percentile

6% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Tanya M. Laidlaw is affiliated with Brigham and Women's Hospital in the United States and conducts research primarily in the field of Medicine. Their work spans several specialized subfields including Physiology, Pharmacology, Immunology and Allergy, Pulmonary and Respiratory Medicine, and Otorhinolaryngology.

The scientist's research focuses on topics related to respiratory and allergic conditions. These include:

  • Asthma and respiratory diseases
  • Sinusitis and nasal conditions
  • Drug-Induced Adverse Reactions
  • Allergic Rhinitis and Sensitization
  • Respiratory and Cough-Related Research
  • Inflammatory mediators and NSAID effects
  • Nasal Surgery and Airway Studies

Recent significant papers authored or co-authored by Tanya M. Laidlaw include:

  • "Chronic Rhinosinusitis with Nasal Polyps and Asthma," 2020, The Journal of Allergy and Clinical Immunology In Practice
  • "SARS-CoV-2 Receptor ACE2 Is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Detected in Specific Cell Subsets across Tissues," 2020, Cell
  • "International consensus statement on allergy and rhinology: rhinosinusitis 2021," 2020, International Forum of Allergy & Rhinology
  • "Adult chronic rhinosinusitis," 2020, Nature Reviews Disease Primers
  • "Human airway mast cells proliferate and acquire distinct inflammation-driven phenotypes during type 2 inflammation," 2021, Science Immunology

The scientist frequently collaborates with several co-authors, including:

  • Kathleen M. Buchheit
  • Jillian C. Bensko
  • Joshua A. Boyce
  • Rachel E. Roditi
  • Nora A. Barrett

Frequent publication venues for Tanya M. Laidlaw's work include:

  • Journal of Allergy and Clinical Immunology
  • The Journal of Allergy and Clinical Immunology In Practice
  • Annals of Allergy Asthma & Immunology
  • International Forum of Allergy & Rhinology
  • Clinical & Experimental Allergy

Best Publications

  • SARS-CoV-2 Receptor ACE2 Is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Detected in Specific Cell Subsets across Tissues.

    Carly G.K. Ziegler;Samuel J. Allon;Sarah K. Nyquist;Ian M. Mbano

  • Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials

    Claus Bachert;Claus Bachert;Joseph K Han;Martin Desrosiers;Peter W Hellings

  • SARS-CoV-2 Receptor ACE2 is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Enriched in Specific Cell Subsets Across Tissues

    Carly Ziegler;Samuel J. Allon;Sarah K. Nyquist;Ian Mbano

  • International consensus statement on allergy and rhinology: rhinosinusitis 2021

    Richard R. Orlandi;Todd T. Kingdom;Timothy L. Smith;Benjamin Bleier

  • Hypersensitivity reactions to chemotherapy: Outcomes and safety of rapid desensitization in 413 cases

    Mariana C. Castells;Nichole M. Tennant;David E. Sloane;F. Ida Hsu

  • Allergic inflammatory memory in human respiratory epithelial progenitor cells.

    Jose Ordovas-Montanes;Daniel F. Dwyer;Daniel F. Dwyer;Sarah K. Nyquist;Kathleen M. Buchheit;Kathleen M. Buchheit

  • Diagnosis and management of NSAID-Exacerbated Respiratory Disease (N-ERD)-a EAACI position paper.

    Marek L. Kowalski;Ioana Agache;Sevim Bavbek;Arzu Bakirtas

  • Chronic Rhinosinusitis with Nasal Polyps and Asthma.

    Tanya M. Laidlaw;Joaquim Mullol;Katharine M. Woessner;Nikhil Amin

  • Cysteinyl leukotriene overproduction in aspirin exacerbated respiratory disease is driven by platelet-adherent leukocytes

    Tanya M. Laidlaw;Tanya M. Laidlaw;Molly S. Kidder;Neil Bhattacharyya;Neil Bhattacharyya;Wei Xing

  • Adult chronic rhinosinusitis.

    Claus Bachert;Claus Bachert;Claus Bachert;Bradley Marple;Rodney J. Schlosser;Claire Hopkins

  • KIT Inhibition by Imatinib in Patients with Severe Refractory Asthma

    Katherine N. Cahill;Howard R. Katz;Jing Cui;Juying Lai

  • Prostaglandin D2: A dominant mediator of aspirin exacerbated respiratory disease

    Katherine N. Cahill;Jillian C. Bensko;Joshua A. Boyce;Joshua A. Boyce;Tanya M. Laidlaw;Tanya M. Laidlaw

  • Safety, Costs, and Efficacy of Rapid Drug Desensitizations to Chemotherapy and Monoclonal Antibodies

    David Sloane;Usha Govindarajulu;Jacob Harrow-Mortelliti;William Barry

  • Thymic stromal lymphopoietin controls prostaglandin D2 generation in patients with aspirin-exacerbated respiratory disease

    Kathleen M. Buchheit;Kathleen M. Buchheit;Katherine N. Cahill;Katherine N. Cahill;Howard R. Katz;Howard R. Katz;Katherine C. Murphy

  • Aspirin-Exacerbated Respiratory Disease--New Prime Suspects.

    Tanya M. Laidlaw;Joshua A. Boyce

  • Human airway mast cells proliferate and acquire distinct inflammation-driven phenotypes during type 2 inflammation.

    Daniel F. Dwyer;Daniel F. Dwyer;Jose Ordovas-Montanes;Samuel J. Allon;Samuel J. Allon;Samuel J. Allon;Kathleen M. Buchheit;Kathleen M. Buchheit

  • Aspirin-Exacerbated Respiratory Disease Involves a Cysteinyl Leukotriene-Driven IL-33-Mediated Mast Cell Activation Pathway

    Tao Liu;Yoshihide Kanaoka;Nora A. Barrett;Chunli Feng

  • Prostaglandin E2 deficiency causes a phenotype of aspirin sensitivity that depends on platelets and cysteinyl leukotrienes

    Tao Liu;Tanya M. Laidlaw;Tanya M. Laidlaw;Howard R. Katz;Joshua A. Boyce;Joshua A. Boyce

  • Dupilumab improves nasal polyp burden and asthma control in patients with CRSwNP and AERD.

    Tanya M. Laidlaw;Joaquim Mullol;Chunpeng Fan;Donghui Zhang

  • Cysteinyl leukotriene receptors, old and new; implications for asthma

    T. M. Laidlaw;J. A. Boyce

  • Pathogenesis of aspirin-exacerbated respiratory disease and reactions.

    Tanya M. Laidlaw;Joshua A. Boyce

Frequent Co-Authors

Joshua A. Boyce
Joshua A. Boyce Brigham and Women's Hospital
Neil Bhattacharyya
Neil Bhattacharyya Massachusetts Eye and Ear Infirmary
Claus Bachert
Claus Bachert Karolinska Institute
Joaquim Mullol
Joaquim Mullol University of Barcelona
Elliot Israel
Elliot Israel Brigham and Women's Hospital
Yoshihide Kanaoka
Yoshihide Kanaoka Brigham and Women's Hospital
Larry Borish
Larry Borish University of Virginia
Neil M.H. Graham
Neil M.H. Graham Regeneron (United States)

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, related healthcare careers offer numerous pathways, including nursing and specialized practitioner roles. Many students begin by exploring LPN programs, and finding lpn schools easy to get into can provide a practical first step into patient care with less stringent admission requirements.

Advancing from LPN roles, aspiring nurses often seek easiest np programs to get into, especially if weighing flexible and accessible options that still prepare them for advanced practice roles. These programs often offer online formats to accommodate busy schedules.

For those focused on mental health within immunology-related fields, becoming a Psychiatric Mental Health Nurse Practitioner (PMHNP) is a notable pathway. Prospective students can explore top psychiatric mental health nurse practitioner programs online to ensure strong clinical placement opportunities that enhance real-world experience.

Cost is another important consideration. Accessing cheapest pmhnp certificate programs can help reduce financial barriers while pursuing valuable credentials in this specialized field.

Best Scientists Citing Tanya M. Laidlaw

Trending Scientists

Recently Published Articles